NCT05970159View on ClinicalTrials.gov

Impact of Preoperative Serum Albumin Level on Postoperative Outcomes in Chinese HCC Patients Treated With Surgery

UnknownOBSERVATIONAL
Enrollment

480

Participants

Timeline

Start Date

August 31, 2023

Primary Completion Date

June 30, 2024

Study Completion Date

March 31, 2025

Conditions
Hepatocellular Carcinoma
Trial Locations (1)

200032

RECRUITING

Zhongshan Hospital, Fudan University, Shanghai

Sponsors

Collaborators (1)

Takeda
All Listed Sponsors
collaborator

Takeda

INDUSTRY

lead

Shanghai Zhongshan Hospital

OTHER